TY  - GEN
AU  - Yoo,Heon Jong
AU  - Kim,Boh-Ram
AU  - Byun,Hyun-Jung
AU  - Park,Sang-Yoon
AU  - Rho,Seung Bae
TI  - BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents
SN  - 1878-5875
PY  - 2014///0114
KW  - 3-Phosphoinositide-Dependent Protein Kinases
KW  - metabolism
KW  - Antimetabolites, Antineoplastic
KW  - pharmacology
KW  - Apoptosis
KW  - genetics
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Cytoskeletal Proteins
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Female
KW  - G1 Phase Cell Cycle Checkpoints
KW  - Human Umbilical Vein Endothelial Cells
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - NF-kappa B
KW  - biosynthesis
KW  - Neovascularization, Pathologic
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Phosphorylation
KW  - drug effects
KW  - Proto-Oncogene Proteins c-akt
KW  - TOR Serine-Threonine Kinases
KW  - Tumor Suppressor Protein p53
KW  - Tumor Suppressor Proteins
KW  - Up-Regulation
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factor Receptor-2
KW  - bcl-2-Associated X Protein
KW  - rho GTP-Binding Proteins
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.biocel.2013.04.001
ER  -